Gene-Tailored drugs aim to tackle tough bile duct cancer
Disease control
Not yet recruiting
This study tests whether targeted drugs or immunotherapies, chosen based on a patient's specific gene mutations, can shrink tumors and extend life in advanced cholangiocarcinoma (bile duct cancer). About 55 adults with unresectable, advanced disease and a targetable gene mutation…
Sponsor: Mao-Lin Yan • Aim: Disease control
Last updated Jun 26, 2026 15:27 UTC